The major focus of the study will be the immune system
Dr. Avindra Nath laid out a three pronged strategy to develop treatments for ME/CFS at the CDC’s Grand Rounds meeting today. The first step is the Clinical Center Study soon to begin. The second step will validate the biomarkers found in the first study. The third is targeted treatments to correct the immune dysfunction he believes he will find.
Check out a short report on his presentation here
A full blog to follow
Like This Blog?
Make Sure You Don’t Miss Another One!
Register for our free ME/CFS, fibromyalgia, and long COVID blogs here.
The Fibro Summit - Natural Ways to Get Better Sleep, Heal the Gut, Reduce Pain
The online Fibro Summit offers natural ways to get better sleep, heal the gut, reduce pain, etc. Register to watch the talks on the day they’re presented or buy the package and download them and watch them at your leisure.
Find out more about the Summit here or register here.
Really glad to see the focus on the brain. I’ve been saying for years that CFS is about the brain, or more specifically the brain/immune interface. A lot of focus now finally going there. Great.
The neuroimmune therapeutics stategy discussed assumes that ongoing viral infection is not present. Current neuroimmune therapeutics can tend to have the unwanted side effect of allowing or encouraging viral infections.
For the first time in decades i am convinced he’s going to found a biomarker 100% 🙂 It is in the spinal fluid i said this for so long. Dr. Avindra Nath is the best specialist in this field. I think a potential nobel price winner 🙂